publication date: Mar. 23, 2018

Conversation with the Cancer Letter

Goldwater’s Coleman: Right to Try patients don’t need permission from feds to save their own lives

Starlee Coleman

Starlee Coleman

Senior policy advisor, Goldwater Institute

 

Patients and their doctors should be able to make treatment decisions without involvement from the federal government, said Starlee Coleman, senior policy advisor for the Goldwater Institute, a libertarian think tank that lobbied successfully for widespread adoption of right-to-try laws.

“We’re genuinely trying to help people, and however that that happens is OK, but it’s just important, I think, for people to note that—especially for your readers—if they want to keep using the expanded access program, they’re going to be able to do that,” Coleman said. “That’s not going anywhere for them.

“We’ve been talking about this issue for four years pretty extensively and it’s like, your audience are the smartest people in this entire debate, right? And the fact that they’re not connecting the most basic dots is so frustrating.”

 

Coleman spoke to Matthew Ong, a reporter with The Cancer Letter.

 

Matthew Ong:

What does the latest right-to-try bill achieve that isn’t currently accomplished by expanded access?

Starlee Coleman:

This is the fundamental difference between right-to-try and expanded access.

Right-to-try essentially eliminates the requirement that patients have to file for permission from the federal government to try an investigational … Continue reading Goldwater’s Coleman: Right to Try patients don’t need permission from feds to save their own lives

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.